Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis

ObjectiveTo prospectively observe changes in the traditional Chinese medicine (TCM) syndromes in children with primary nephrotic syndrome(PNS) before and after the rituximab (RTX) treatment, thus summarizing evolution patterns and prognostic impact of TCM syndromes types.MethodEighty-nine PNS childr...

Full description

Saved in:
Bibliographic Details
Main Authors: Ai Yi-ying, Wu Rui-bo, Wen Zi-long, Xu Kai-si
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2025-06-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.003
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849424398625275904
author Ai Yi-ying
Wu Rui-bo
Wen Zi-long
Xu Kai-si
author_facet Ai Yi-ying
Wu Rui-bo
Wen Zi-long
Xu Kai-si
author_sort Ai Yi-ying
collection DOAJ
description ObjectiveTo prospectively observe changes in the traditional Chinese medicine (TCM) syndromes in children with primary nephrotic syndrome(PNS) before and after the rituximab (RTX) treatment, thus summarizing evolution patterns and prognostic impact of TCM syndromes types.MethodEighty-nine PNS children treated with RTX at pediatric inpatient department of Guangdong Provincial Hospital of Chinese Medicine from Jan 2023 to Dec 2023 were included. General information and TCM syndrome data before and after RTX treatment were collected via a TCM syndrome observation form. TCM syndrome differentiation was performed using form-recorded data. Data on TCM syndrome types (days 0, 30, and 60) and 6-month recurrence were entered into an Access database. Statistical analysis of the data was performed using SPSS 26.0.ResultsFor deficiency syndromes, pre-treatment dominant types on day 0 were dominantly the lung-spleen Qi deficiency (37.1%) and spleen-kidney Yang deficiency (57.3%). At 30 days post-treatment, the proportions of liver-kidney Yin deficiency rose to 42.7% and Qi-Yin deficiency emerged (12.4%). By day 60, the proportions of liver-kidney Yin deficiency (51.7%) and Qi-Yin deficiency (15.7%) further increased, with the lung-spleen Qi deficiency (12.4%) and spleen-kidney Yang deficiency (20.2%) continuing to decline. For excess syndromes, pre-treatment dominant concurrent syndrome on day 0 was water-dampness (32.6%), followed by blood stasis (24.7%) and damp-turbidity (21.3%). At 30 days post-treatment, wind pathogen (16.9%) became the most common concurrent syndrome. By day 60, external wind (21.3%), blood stasis (18.0%), and damp-heat (16.9%) were the leading concurrent syndromes. Significant differences existed in deficiency/empirical syndrome distributions across time points (<italic>P</italic>&lt;0.05). The liver-kidney Yin deficiency syndrome on day 30 significantly influenced the recurrence of PNS within 3-6 months(OR=0.058, 95% <italic>CI</italic>: 0.07-0.491, <italic>P</italic>=0.009&lt;0.05).ConclusionThere is a certain pattern in the evolution of TCM syndromes in children with PNS after RTX treatment. Pre-treatment dominant deficiencies are mainly the spleen-kidney Yang deficiency and lung-spleen Qi deficiency. At post-treatment, liver-kidney Yin deficiency and Qi-Yin dual deficiency increased significantly. Prognostically, the syndrome of liver-kidney Yin deficiency at day 30 post-treatment predicts a reduced recurrence risk of PNS at 3-6 months in children.
format Article
id doaj-art-53fcdfae16754e3fa4d66705165f4e49
institution Kabale University
issn 1671-2390
language zho
publishDate 2025-06-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-53fcdfae16754e3fa4d66705165f4e492025-08-20T03:30:10ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902025-06-0125457464112447505Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosisAi Yi-yingWu Rui-boWen Zi-longXu Kai-siObjectiveTo prospectively observe changes in the traditional Chinese medicine (TCM) syndromes in children with primary nephrotic syndrome(PNS) before and after the rituximab (RTX) treatment, thus summarizing evolution patterns and prognostic impact of TCM syndromes types.MethodEighty-nine PNS children treated with RTX at pediatric inpatient department of Guangdong Provincial Hospital of Chinese Medicine from Jan 2023 to Dec 2023 were included. General information and TCM syndrome data before and after RTX treatment were collected via a TCM syndrome observation form. TCM syndrome differentiation was performed using form-recorded data. Data on TCM syndrome types (days 0, 30, and 60) and 6-month recurrence were entered into an Access database. Statistical analysis of the data was performed using SPSS 26.0.ResultsFor deficiency syndromes, pre-treatment dominant types on day 0 were dominantly the lung-spleen Qi deficiency (37.1%) and spleen-kidney Yang deficiency (57.3%). At 30 days post-treatment, the proportions of liver-kidney Yin deficiency rose to 42.7% and Qi-Yin deficiency emerged (12.4%). By day 60, the proportions of liver-kidney Yin deficiency (51.7%) and Qi-Yin deficiency (15.7%) further increased, with the lung-spleen Qi deficiency (12.4%) and spleen-kidney Yang deficiency (20.2%) continuing to decline. For excess syndromes, pre-treatment dominant concurrent syndrome on day 0 was water-dampness (32.6%), followed by blood stasis (24.7%) and damp-turbidity (21.3%). At 30 days post-treatment, wind pathogen (16.9%) became the most common concurrent syndrome. By day 60, external wind (21.3%), blood stasis (18.0%), and damp-heat (16.9%) were the leading concurrent syndromes. Significant differences existed in deficiency/empirical syndrome distributions across time points (<italic>P</italic>&lt;0.05). The liver-kidney Yin deficiency syndrome on day 30 significantly influenced the recurrence of PNS within 3-6 months(OR=0.058, 95% <italic>CI</italic>: 0.07-0.491, <italic>P</italic>=0.009&lt;0.05).ConclusionThere is a certain pattern in the evolution of TCM syndromes in children with PNS after RTX treatment. Pre-treatment dominant deficiencies are mainly the spleen-kidney Yang deficiency and lung-spleen Qi deficiency. At post-treatment, liver-kidney Yin deficiency and Qi-Yin dual deficiency increased significantly. Prognostically, the syndrome of liver-kidney Yin deficiency at day 30 post-treatment predicts a reduced recurrence risk of PNS at 3-6 months in children.http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.003Primary nephrotic syndrome in childrenRituximabTCM syndromesPrognosis
spellingShingle Ai Yi-ying
Wu Rui-bo
Wen Zi-long
Xu Kai-si
Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
Linchuang shenzangbing zazhi
Primary nephrotic syndrome in children
Rituximab
TCM syndromes
Prognosis
title Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
title_full Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
title_fullStr Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
title_full_unstemmed Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
title_short Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
title_sort study on the evolution of the traditional chinese medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
topic Primary nephrotic syndrome in children
Rituximab
TCM syndromes
Prognosis
url http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.003
work_keys_str_mv AT aiyiying studyontheevolutionofthetraditionalchinesemedicinesyndromesofprimarynephroticsyndrometreatedwithrituximabinchildrenandtheprognosis
AT wuruibo studyontheevolutionofthetraditionalchinesemedicinesyndromesofprimarynephroticsyndrometreatedwithrituximabinchildrenandtheprognosis
AT wenzilong studyontheevolutionofthetraditionalchinesemedicinesyndromesofprimarynephroticsyndrometreatedwithrituximabinchildrenandtheprognosis
AT xukaisi studyontheevolutionofthetraditionalchinesemedicinesyndromesofprimarynephroticsyndrometreatedwithrituximabinchildrenandtheprognosis